Elite Pharmaceuticals, Inc. (OTC: ELTP)
TNS members were alerted to OTC traded ELTP at $.09 on pending drug trials. ELTP closed on 10/20/09 at .25 yielding a 28% ROI.
TooNiceStocks.com was not compensated for profiling this company. Rather we have initiated our own independent research. As always read full disclaimer here.


